investment partner Jay Rughani reflected on the challenges faced in healthcare in 2023, including health worker burnout, staffing shortages, and health disparities. However, he remains optimistic about the potential of digital health and modern technology to improve efficiency and accessibility in healthcare. Rughani discussed the potential of AI in healthcare for 2024, focusing on implementing technology in an enterprise context and the development of AI teammates to aid healthcare workers. He highlighted the impact of AI and GLP-1 drugs in 2023 and offered recommendations for regulators forming rules around AI in healthcare, emphasizing the need for thoughtful regulation that doesn’t stifle innovation. Lastly, he addressed the challenge of regulatory bodies keeping up with the rapid pace of technological change in the field of AI.
Source link
Andreessen Horowitz on digital health funding in 2024 and AI regulation
